Arterial hypertension is an hard cardiovascular risk factor, being responsible for an high occurrence of cardiovascular adverse events such as myocardial infarction, stroke and congestive heart failure. However, hypertension rarely is the only contributor to such events since in most of cases the presence of elevated blood pressure values is associated with other conditions, particularly obesity, hypercholesterolemia, atherogenic dyslipidemia and diabetes mellitus. The presence of these conditions sensibly increases the level of risk, thus leading to an high morbidity and mortality. Indeed, most of adverse events related to hypertension are observed in patients with a mild increase of blood pressure levels suggesting that the concomitant presence of other risk factors significantly contributes to the overall risk. Moreover, it has been shown that untreated hypertension produces preclinical damages on cardiovascular system (heart, kidneys, vessels), further increasing the global risk. Indeed, left ventricular hypertrophy, microalbuminuria and vascular alterations are all independent predictors of cardiovascular morbidity and mortality. Based on these considerations, the current European hypertension guidelines are now drawing the attention to the concept of a global approach to cardiovascular risk in the management of hypertension. In fact, this strategy can lead to a better risk stratification of hypertensives based on the integrated evaluation of their risk factors, thus guiding the physicians to the choice of the most suitable therapeutic strategy to reduce the global cardiovascular risk of these patients.
Keywords: Hypertension, cardiovascular disease, global approach, risk management
GLP-1 as a Therapeutic Agent in Patients with Type 2 Diabetes Mellitus
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Under Re-organization) Goto-kakizaki Rats: Its Suitability as Non-obese Diabetic Animal Model for Spontaneous Type 2 Diabetes Mellitus
Current Diabetes Reviews Biology and Therapeutic Applications of Peroxisome Proliferator- Activated Receptors
Current Topics in Medicinal Chemistry Metformin Restrains Pancreatic Duodenal Homeobox-1 (PDX-1) Function by Inhibiting ERK Signaling in Pancreatic Ductal Adenocarcinoma.
Current Molecular Medicine Genetic Variations and Subclinical Markers of Carotid Atherosclerosis in Patients with Type 2 Diabetes Mellitus
Current Vascular Pharmacology Vitamin D and Stroke: Promise for Prevention and Better Outcome
Current Vascular Pharmacology Effects of Polyphenolic Derivatives on Heme Oxygenase-System in Metabolic Dysfunctions
Current Medicinal Chemistry Pharmacogenetics of Glucagon-like Peptide-1 Agonists for the Treatment of Type 2 Diabetes Mellitus
Current Clinical Pharmacology Cardiac Complications in Hypertension and Diabetes: Role of Sympathetic Nervous Activity
Current Hypertension Reviews Recent Progress and Related Patents on the Applications of Bone Marrow-Derived Stem/Progenitor Cells in Regenerative Medicine and Cancer Therapies
Recent Patents on Regenerative Medicine (Discontinued) Role of the Decreased Nitric Oxide Bioavailability in the Vascular Complications of Diabetes Mellitus
Current Pharmaceutical Biotechnology Role of Oxidative Stress in the Genesis of Atherosclerosis and Diabetes Mellitus: A Personal Look Back on 50 Years of Research
Current Aging Science Prooxidant-Antioxidant Balance and Antioxidant Properties of Thuja orientalis L: A Potential Therapeutic Approach for Diabetes Mellitus
Current Molecular Pharmacology Selective Peroxisome Proliferator-Activated Receptor-γ Modulation to Reduce Cardiovascular Risk in Patients with Insulin Resistance
Recent Patents on Cardiovascular Drug Discovery (Discontinued) Should Adipokines be Considered in the Choice of the Treatment of Obesity-Related Health Problems?
Current Drug Targets Self Monitoring of Blood Glucose Among Patients with Type 2 Diabetes Mellitus in Eastern Nigeria: Need for Multi-strategic Interventions
Current Diabetes Reviews Editorial [Hot Topic: Management of Diabetes Mellitus: The Five Pillars of Wisdom (Guest Editors: C.D.A. Stehouwer, N.C. Schaper and M. Huijberts)]
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Under Re-organization) A Review of Sodium Glucose Co-transporter 2 Inhibitors Canagliflozin, Dapagliflozin and Empagliflozin
Cardiovascular & Hematological Agents in Medicinal Chemistry Gene Variation of Endoplasmic Reticulum Aminopeptidase 1 and Risk of Incident Type 2 Diabetes Mellitus amongst 22,718 Initially Healthy Women
Clinical Immunology, Endocrine & Metabolic Drugs (Discontinued) Effects of Moringa oleifera on Insulin Levels and Folliculogenesis in Polycystic Ovary Syndrome Model with Insulin Resistance
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Under Re-organization)